Concr welcomes Oncology Ventures as investors

16 Aug 2023

We are delighted to welcome Oncology Ventures as investors in the second tranche of our oversubscribed seed round.

Investing in cancer-focused data, infrastructure, IT and services companies, Oncology Ventures are looking to fundamentally change the way cancer care is designed and delivered at scale. This mission directly aligns with Concr’s drive to enable precision medicine through data, and we look forward to working together on forging a new path for better cancer treatment and care.

Read about Oncology Ventures investment thesis and why they made their 4th investment in Concr, here.